JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Scope & Guideline
Advancing knowledge in gastrointestinal and liver health.
Introduction
Aims and Scopes
- Gastrointestinal Disorders and Diseases:
Research includes studies on various gastrointestinal disorders such as inflammatory bowel disease (IBD), functional gastrointestinal disorders, and colorectal cancer, with a focus on their pathophysiology, diagnosis, and treatment. - Liver Diseases and Hepatology:
The journal publishes extensive research on liver diseases, including hepatitis B and C, liver cirrhosis, hepatocellular carcinoma, and metabolic-associated fatty liver disease, emphasizing disease mechanisms, clinical management, and therapeutic advancements. - Endoscopic Techniques and Innovations:
A significant focus is placed on the development and evaluation of endoscopic techniques, including endoscopic submucosal dissection, capsule endoscopy, and advanced imaging modalities, aimed at improving diagnostic and therapeutic outcomes. - Microbiome and Metabolism:
Research on the gut microbiome's role in gastrointestinal and liver diseases is prevalent, particularly studies exploring microbiota composition, metabolic pathways, and their implications for disease management and treatment efficacy. - Clinical Trials and Therapeutic Interventions:
The journal features clinical trial results and studies evaluating new therapeutic agents, including biologics and novel pharmacological treatments, highlighting their effectiveness and safety in managing gastrointestinal and liver conditions. - Public Health and Epidemiology:
Contributions addressing the epidemiological aspects of gastrointestinal and liver diseases, including prevalence studies, risk factors, and public health interventions, are integral to the journal's scope.
Trending and Emerging
- Metabolic Dysfunction-Associated Liver Disease (MAFLD):
Research on metabolic dysfunction-associated fatty liver disease has gained prominence, with studies exploring its pathogenesis, management strategies, and implications for patient outcomes. - Artificial Intelligence in Gastroenterology:
The integration of artificial intelligence and machine learning technologies in diagnostic processes and treatment planning has become a significant focus, enhancing the accuracy and efficiency of clinical practices. - Gut Microbiome Research:
There is an increasing emphasis on understanding the role of the gut microbiome in gastrointestinal and liver diseases, with studies investigating its impact on disease progression and treatment responses. - Personalized Medicine Approaches:
Personalized and precision medicine approaches in treating inflammatory bowel disease and hepatological conditions are emerging as a key area, reflecting a shift towards individualized patient care based on genetic and phenotypic markers. - Telehealth and Virtual Care Models:
The COVID-19 pandemic has accelerated the adoption of telehealth and virtual care models, with ongoing research evaluating their effectiveness in managing gastrointestinal diseases and improving patient access to care. - Patient-Reported Outcomes and Quality of Life:
An increasing number of studies are focusing on patient-reported outcomes and health-related quality of life, particularly in chronic conditions like IBD and liver diseases, emphasizing the importance of patient perspectives in treatment evaluation.
Declining or Waning
- Traditional Pharmacological Approaches:
There has been a noticeable reduction in studies focusing solely on traditional pharmacological treatments for gastrointestinal and liver diseases, as interest shifts towards novel therapies and precision medicine. - Surgical Techniques in Gastroenterology:
Research pertaining to conventional surgical techniques has waned, with a growing preference for minimally invasive endoscopic procedures and innovative technologies for treatment. - Epidemiological Studies of Common Conditions:
While public health remains important, there is a decline in the volume of epidemiological studies focusing solely on common gastrointestinal conditions, as researchers increasingly target specific populations or emerging diseases. - General Reviews of Established Guidelines:
The publication of general reviews summarizing established clinical guidelines has decreased, as the focus has shifted towards innovative practices and real-world applications of new treatments.
Similar Journals
Saudi Journal of Gastroenterology
Unlocking insights into gastrointestinal health.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Fostering collaboration in the field of digestive health.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
Journal of Gastrointestinal and Liver Diseases
Exploring Innovations in Digestive MedicineThe Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.
With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Connecting Researchers and Clinicians in Digestive HealthAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.
Frontline Gastroenterology
Advancing the Frontiers of GastroenterologyFrontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.
Gastrointestinal Disorders
Advancing Gastrointestinal Health Through Open Access ResearchGastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.
Clinical Gastroenterology and Hepatology
Pioneering Research for Tomorrow's Gastroenterological SolutionsClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
DIGESTIVE AND LIVER DISEASE
Transforming the landscape of liver disease research.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
Gastroenterology Insights
Unlocking New Perspectives in GastroenterologyGastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Empowering Clinicians with Cutting-Edge Gastrointestinal InsightsSCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.